🔎 Trials Near Me

Utama › Penyakit Payudara › California

Kajian klinikal Penyakit Payudara di California

6 kajian untuk Penyakit Payudara sedang mencari peserta di lokasi di California.

Bandar di California

Teks kajian rasmi (Bahasa Inggeris)

ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health

  • UC Davis, Sacramento
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 94 · Wanita · Dikemas kini 17 Sep 2026 · NCT07505797

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

  • University of California, Los Angeles (Specimen Analysis only), Los Angeles
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06780176

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

  • Providence Medical Foundation, Fullerton
  • California Research Institute, Los Angeles
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT05386108

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

  • Research Site, Duarte
  • Research Site, Palo Alto
Mengambil pesertaFasa 3
Umur 18 hingga 130 · Semua jantina · Dikemas kini 8 Sep 2026 · NCT07647328

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • Ellison Clinic at Saint John's, Los Angeles
  • UCSF Medical Center at Mission Bay, San Francisco
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT05768139

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jun 2026 · NCT06993844

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.